{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:45:50Z","timestamp":1773665150570,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007273","name":"Comisi\u00f3n Interministerial de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["SAF 97\u20130173"],"award-info":[{"award-number":["SAF 97\u20130173"]}],"id":[{"id":"10.13039\/501100007273","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"crossref","award":["CTS-109"],"award-info":[{"award-number":["CTS-109"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Willias Masocha"},{"DOI":"10.13039\/501100004892","name":"Agencia Espa\u00f1ola de Cooperaci\u00f3n Internacional","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004892","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejphar.2016.01.010","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T16:00:47Z","timestamp":1453824047000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Distinguishing subgroups among \u03bc-opioid receptor agonists using Na+,K+-ATPase as an effector mechanism"],"prefix":"10.1016","volume":"774","author":[{"given":"Willias","family":"Masocha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Agil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.01.010_bib1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0022-3565(25)23036-1","article-title":"Assessment of relative intrinsic activity of \u03bc-opioid analgesics in vivo by using \u03b2-funaltrexamine","volume":"255","author":"Adams","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.01.010_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2796.2006.01745.x","article-title":"New roles for an old enzyme: Na+,K+-ATPase emerges as an interesting drug target","volume":"261","author":"Aperia","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2016.01.010_bib3","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1074\/jbc.270.12.6702","article-title":"Location of regions of the opioid receptor involved in selective agonist binding","volume":"270","author":"Fukuda","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.01.010_bib4","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1046\/j.1460-9568.1998.00267.x","article-title":"Influence of Gz and Gi2 transducer proteins in the activity of opioid agonists to \u03bc receptors","volume":"10","author":"Garz\u00f3n","year":"1988","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2016.01.010_bib5","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.bcp.2012.02.023","article-title":"Changes in morphine-induced activation of cerebral Na+,K+-ATPase during morphine tolerance: Biochemical and behavioral consequences","volume":"83","author":"Gonz\u00e1lez","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(89)90764-4","article-title":"Modulation of \u03bc-mediated antinociception by \u03b4 agonists in the mouse: selective potentiation of morphine and normorphine by [d-Pen2,d-Pen5]enkephalin","volume":"164","author":"Heyman","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-2999(02)02813-3","article-title":"Evaluation of endomorphin-1 on the activity of Na+,K+-ATPase using in vitro and in vivo studies","volume":"458","author":"Horvath","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(91)90512-O","article-title":"Evaluation of receptor mechanisms mediating fentanyl analgesia and toxicity","volume":"197","author":"Jang","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0022-3565(25)12740-7","article-title":"Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse","volume":"254","author":"Jiang","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.01.010_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.01.010_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-8993(02)03663-6","article-title":"Mechanisms involved in morphine-induced activation of synaptosomal Na+,K+-ATPase","volume":"957","author":"Masocha","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2016.01.010_bib12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/jpet.103.052977","article-title":"Role of Na+,K+-ATPase in morphine-induced antinociception","volume":"306","author":"Masocha","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.01.010_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0165-6147(93)90019-G","article-title":"Mechanisms of multifunctional signalling by G protein-linked receptors","volume":"14","author":"Milligan","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2016.01.010_bib14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1476-5381.1995.tb13346.x","article-title":"Subgroups among \u03bc-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs","volume":"114","author":"Oca\u00f1a","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-5793(94)01341-W","article-title":"DAMGO, a \u03bc-opioid receptor selective agonist, distinguishes between \u03bc- and \u03b4-opioid receptors around their first extracellular loops","volume":"357","author":"Onogi","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2016.01.010_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)10719-2","article-title":"Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine and fentanyl","volume":"262","author":"Paronis","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.01.010_bib17","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.2013.53.1079","article-title":"Opiate pharmacology and relief of pain","volume":"32","author":"Pasternak","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib18","series-title":"An Introduction to Medicinal Chemistry","first-page":"249","volume":"12","author":"Patrick","year":"2013"},{"key":"10.1016\/j.ejphar.2016.01.010_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(92)90879-9","article-title":"Opioid efficacy is linked to the LiCl-sensitive inositol-1,4,5-triphosphate-restorable pathway","volume":"217","author":"Raffa","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib20","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0014-2999(94)90073-6","article-title":"G-protein antisense oligodeoxyribonucleotides and \u03bc-opioid supraspinal antinociception","volume":"258","author":"Raffa","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0014-2999(88)90732-7","article-title":"Pertussis toxin differentially reduces the efficacy of opioids to produce supraspinal analgesia in the mouse","volume":"152","author":"S\u00e1nchez-Bl\u00e1zquez","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0361-9230(00)00448-2","article-title":"Agonists determine the pattern of G-protein activation in \u03bc-receptor-mediated supraspinal analgesia","volume":"54","author":"S\u00e1nchez-Bl\u00e1zquez","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2016.01.010_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)35065-7","article-title":"Endomorphin-1 and endomorphin-2 show differences in their activation of mu opioid receptor-regulated G proteins in supraspinal antinociception in mice","volume":"291","author":"S\u00e1nchez-Bl\u00e1zquez","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.01.010_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(89)90059-9","article-title":"Intracerebroventricular N-ethylmaleimide differentially reduced supraspinal opioid analgesia","volume":"166","author":"S\u00e1nchez-Bl\u00e1zquez","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0361-9230(98)00058-6","article-title":"Role of opioidergic and monoaminergic neurotransmission in the GnRH release mechanism of EBP-primed OVX rats","volume":"47","author":"Sharma","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2016.01.010_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0306-3623(88)90046-8","article-title":"Droperidol enhances fentanyl and sufentanil, but not morphine, antinociception","volume":"19","author":"Statile","year":"1988","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib27","doi-asserted-by":"crossref","first-page":"C541","DOI":"10.1152\/ajpcell.2000.279.3.C541","article-title":"Mechanisms of sodium pump regulation","volume":"279","author":"Therien","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/mol.106.029561","article-title":"Involvement of dopamine system in regulation of Na+,K+-ATPase in the striatum upon activation of opioid receptors by morphine","volume":"71","author":"Wu","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1124\/mol.105.016501","article-title":"Involvement of cAMP\/cAMP-dependent protein kinase signaling pathway in regulation of Na+,K+-ATPase upon activation of opioid receptors by morphine","volume":"69","author":"Wu","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.01.010_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0014-5793(96)00312-2","article-title":"The region in the \u03bc opioid receptor conferring selectivity for sufentanil over the \u03b4 receptor is different from that over the \u03ba receptor","volume":"384","author":"Zhu","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2016.01.010_bib31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0022-5347(25)00270-8","article-title":"Use of \u03b2-funaltrexamine to determine \u03bc opioid receptor involvement in the analgesic activity of various opioid ligands","volume":"241","author":"Zimmerman","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916300127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916300127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T07:08:02Z","timestamp":1748761682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916300127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":31,"alternative-id":["S0014299916300127"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.01.010","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinguishing subgroups among \u03bc-opioid receptor agonists using Na+,K+-ATPase as an effector mechanism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}